{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06133101",
            "orgStudyIdInfo": {
                "id": "2023-0416"
            },
            "organization": {
                "fullName": "Children's Hospital Medical Center, Cincinnati",
                "class": "OTHER"
            },
            "briefTitle": "Impact of Soymilk on Liver Disease Severity of Children With Non-alcoholic Fatty Liver Disease (NAFLD)",
            "officialTitle": "Impact of Soymilk on Liver Disease Severity of Children With Non-alcoholic Fatty Liver Disease (NAFLD)",
            "therapeuticArea": [
                "Gastroenterology"
            ],
            "study": "impact-of-soymilk-on-liver-disease-severity-of-children-with-non-alcoholic-fatty-liver-disease-nafld"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-03",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-01-15",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-03",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-06",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-10-13",
            "studyFirstSubmitQcDate": "2023-11-09",
            "studyFirstPostDateStruct": {
                "date": "2023-11-15",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-03-10",
            "lastUpdatePostDateStruct": {
                "date": "2024-03-12",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR_INVESTIGATOR",
                "investigatorFullName": "Marialena Mouzaki",
                "investigatorTitle": "Professor, Division of Gastroenterology, Hepatology and Nutrition",
                "investigatorAffiliation": "Children's Hospital Medical Center, Cincinnati"
            },
            "leadSponsor": {
                "name": "Marialena Mouzaki",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "A randomized, controlled study of standard soy milk consumption compared to 2% fat cow's milk consumption in children with Non-alcoholic Fatty Liver Disease (NAFLD). The investigators hypothesize that the daily consumption of soy isoflavones found in the soy milk will be beneficial in reducing NAFLD and other obesity-related comorbidities. The investigators do not expect any adverse endocrine or metabolomic effects from the consumption of soy isoflavones."
        },
        "conditionsModule": {
            "conditions": [
                "Non-Alcoholic Fatty Liver Disease"
            ],
            "keywords": [
                "NAFLD"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "interventionModelDescription": "Prospective parallel arm randomized controlled study",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "SINGLE",
                    "whoMasked": [
                        "INVESTIGATOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 44,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "2% Fat Cows Milk",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "Participants randomized to this arm will consume 2% fat cow's milk twice daily for 12 weeks.",
                    "interventionNames": [
                        "Drug: 2% Fat Cow's Milk"
                    ]
                },
                {
                    "label": "Standard Soy Milk",
                    "type": "EXPERIMENTAL",
                    "description": "Participants randomized to this arm will consume standard soy milk twice daily for 12 weeks.",
                    "interventionNames": [
                        "Drug: Standard Soy Milk"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Standard Soy Milk",
                    "description": "Consumption of commercially available soy milk",
                    "armGroupLabels": [
                        "Standard Soy Milk"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "2% Fat Cow's Milk",
                    "description": "Consumption of commercially available 2% cow's milk",
                    "armGroupLabels": [
                        "2% Fat Cows Milk"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Change in liver disease severity",
                    "description": "Change in liver disease severity, measured using magnetic resonance imaging-proton density fat fraction (MRI-PDFF). A relative PDFF change of 30% correlates with histologic improvement in patients with NAFLD and is commonly used in clinical trials.",
                    "timeFrame": "12 weeks"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Change in serum aminotransferase levels (ALT, aspartate aminotransferase [AST], GGT, alkaline phosphatase [ALP])",
                    "timeFrame": "12 weeks"
                },
                {
                    "measure": "Change in gamma glutamyl-transferase levels (GGT)",
                    "timeFrame": "12 weeks"
                },
                {
                    "measure": "Change in alkaline phosphatase (ALP)",
                    "timeFrame": "12 weeks"
                },
                {
                    "measure": "Change in fasting triglycerides",
                    "timeFrame": "12 weeks"
                },
                {
                    "measure": "Change in total cholesterol (TC)",
                    "timeFrame": "12 weeks"
                },
                {
                    "measure": "Change in high- and low-density lipoprotein (HDL-C, LCL-C) levels",
                    "timeFrame": "12 weeks"
                },
                {
                    "measure": "Change in glucose",
                    "timeFrame": "12 weeks"
                },
                {
                    "measure": "Change in insulin",
                    "timeFrame": "12 weeks"
                },
                {
                    "measure": "Change in glycated hemoglobin (HbA1c)",
                    "timeFrame": "12 weeks"
                },
                {
                    "measure": "Change in testosterone, estrogen and sex hormone binding globulin (SHBG) levels",
                    "timeFrame": "12 weeks"
                },
                {
                    "measure": "Change in thyroid function (TSH and Free T4)",
                    "timeFrame": "12 weeks"
                },
                {
                    "measure": "Change in estradiol",
                    "timeFrame": "12 weeks"
                },
                {
                    "measure": "Change in serum metabolome and lipidome",
                    "timeFrame": "12 weeks"
                },
                {
                    "measure": "Change in systolic and diastolic blood pressure",
                    "timeFrame": "12 weeks"
                },
                {
                    "measure": "Change in equol production status",
                    "timeFrame": "12 weeks"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Children with overweight/obesity\n* Non-alcoholic fatty liver disease (NAFLD) and an MRI PDFF \\>10%\n* Known NAFLD or elevated ALT for sex (\\>22 for females and \\>26 for males)\n\nExclusion Criteria:\n\n* MRI-PDFF \\<10%\n* Baseline habitual (\\>3 days per week) consumption of soy foods\n* Allergy to soy or cow's milk protein\n* Inability to undergo MRI\n* Recent (past 8 weeks) antibiotic exposure\n* Treatment for existing endocrine disorders",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "5 Years",
            "maximumAge": "12 Years",
            "stdAges": [
                "CHILD"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Allison Sullivan",
                    "role": "CONTACT",
                    "phone": "513-803-1065",
                    "email": "allison.sullivan2@cchmc.org"
                }
            ],
            "locations": [
                {
                    "facility": "Cincinnati Children's Hospital Medical Center",
                    "status": "RECRUITING",
                    "city": "Cincinnati",
                    "state": "Ohio",
                    "zip": "45229",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Allison Sullivan",
                            "role": "CONTACT",
                            "phone": "513-803-1065",
                            "email": "allison.sullivan2@cchmc.org"
                        },
                        {
                            "name": "Marialena Mouzaki, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.12713,
                        "lon": -84.51435
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000008107",
                    "term": "Liver Diseases"
                },
                {
                    "id": "D000005234",
                    "term": "Fatty Liver"
                },
                {
                    "id": "D000065626",
                    "term": "Non-alcoholic Fatty Liver Disease"
                }
            ],
            "ancestors": [
                {
                    "id": "D000004066",
                    "term": "Digestive System Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M8375",
                    "name": "Fatty Liver",
                    "asFound": "Fatty Liver",
                    "relevance": "HIGH"
                },
                {
                    "id": "M30540",
                    "name": "Non-alcoholic Fatty Liver Disease",
                    "asFound": "Non-alcoholic Fatty Liver Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11107",
                    "name": "Liver Diseases",
                    "asFound": "Liver Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7255",
                    "name": "Digestive System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8883",
                    "name": "Gastrointestinal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T5868",
                    "name": "Visceral Steatosis",
                    "asFound": "Fatty Liver",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC06",
                    "name": "Digestive System Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M11110",
                    "name": "Liver Extracts",
                    "relevance": "LOW"
                },
                {
                    "id": "T294",
                    "name": "Soy Bean",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Hemat",
                    "name": "Hematinics"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "HB",
                    "name": "Herbal and Botanical"
                }
            ]
        }
    },
    "hasResults": false
}